A Phase I Clinical Trial of Repeated Dose Intrapleural Adenoviral-Mediated Interferon-Beta (BG00001, Ad.hIFN-beta) for Pleural Malignancies.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Interferon-beta gene therapy; Nadofaragene-firadenovec
- Indications Mesothelioma
- Focus Adverse reactions
- 29 Sep 2010 Planned end date changed from 1 Mar 2008 to 1 Mar 2023 as reported by ClinicalTrials.gov.
- 29 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Apr 2009 New trial record